Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
GSK reported to have started the sale of $1.2 billion consumer health drugs
According to Reuters, GSK has started the sale of some consumer health brands as it seeks to raise £1 billion.
China announces generic drug list to reduce pharmaceutical costs
Chinese government introduces initiative to enable generic drugs to enter market and reduce prices.
San Francisco bans sales of e-cigarettes from 2020
A unanimous vote by San Francisco's Board of Supervisors has effectively banned the sale of e-cigarettes in the city.
Glenmark has wind knocked out of NDA for respiratory drug by FDA
India’s Glenmark, a generic drug maker that intends to make a splash in the branded drug market, will later this year spin off the unit that will develop and manufacture its new drug offerings.
Progress at Sun's Halol, India, plant tarnished by new FDA findings
Sun Pharmaceutical has struggled to meet FDA expectations for the manufacturing lines at its key launch plant in Halol, India.
AMAG Pharmaceuticals Announces FDA Approval of Vyleesi (bremelanotide injection) for Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
WALTHAM, Mass.
AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan
(Reuters) - Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of the biggest name in medical aesthetics to help reduce its reli...
Phenols in cocoa bean shells may reverse obesity-related problems in mouse cells
A new study by researchers at the University of Illinois suggests that three of the phenolic compounds in cocoa bean shells have powerful effects on the fat and immune cells in mice, potentially rever...
Talzenna bags EU approval for gBRCA-mutated breast cancer
The European Commission has announced the approval of Pfizer’s Talzenna (talazoparib) for patients with inherited BRCA-mutated locally advanced or metatastatic breast cancer.
Sanofi, Regeneron successful in phase II asthma trial
Sanofi and Regeneron have announced that the investigational IL-33 antibody REGN3500 (SAR440340) met its primary and secondary endpoints in the joint phase II proof-of-concept trial.
FDA Approves SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of CF in Children Ages 6-11 Years with Certain Mutations in the CFTR Gene
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq.
A new drug target for chemically induced Parkinson's disease
More than three decades ago, scientists discovered that a chemical found in a synthetic opioid, MPTP, induced the onset of a form of Parkinson's disease.
408
409
410
411
412
413
414
415
416
